Atrys Health Statistics

Total Valuation

Atrys Health has a market cap or net worth of EUR 216.37 million. The enterprise value is 451.03 million.

Market Cap	216.37M
Enterprise Value	451.03M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Atrys Health has 75.92 million shares outstanding. The number of shares has increased by 0.16% in one year.

Current Share Class	n/a
Shares Outstanding	75.92M
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	12.77%
Float	41.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.99
PB Ratio	0.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	72.19
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.53, with an EV/FCF ratio of -360.82.

EV / Earnings	-14.19
EV / Sales	2.07
EV / EBITDA	17.53
EV / EBIT	234.91
EV / FCF	-360.82

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.01.

Current Ratio	0.89
Quick Ratio	0.75
Debt / Equity	1.01
Debt / EBITDA	9.93
Debt / FCF	-204.32
Interest Coverage	0.08

Financial Efficiency

Return on equity (ROE) is -11.73% and return on invested capital (ROIC) is 0.23%.

Return on Equity (ROE)	-11.73%
Return on Assets (ROA)	0.20%
Return on Invested Capital (ROIC)	0.23%
Return on Capital Employed (ROCE)	0.40%
Revenue Per Employee	118,467
Profits Per Employee	-17,259
Employee Count	2,045
Asset Turnover	0.36
Inventory Turnover	99.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.39% in the last 52 weeks. The beta is 0.78, so Atrys Health's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-3.39%
50-Day Moving Average	3.19
200-Day Moving Average	3.29
Relative Strength Index (RSI)	38.88
Average Volume (20 Days)	65,595

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Atrys Health had revenue of EUR 218.10 million and -31.77 million in losses. Loss per share was -0.42.

Revenue	218.10M
Gross Profit	55.92M
Operating Income	1.92M
Pretax Income	-33.47M
Net Income	-31.77M
EBITDA	19.32M
EBIT	1.92M
Loss Per Share	-0.42

Full Income Statement

Balance Sheet

The company has 20.88 million in cash and 255.40 million in debt, giving a net cash position of -234.52 million or -3.09 per share.

Cash & Cash Equivalents	20.88M
Total Debt	255.40M
Net Cash	-234.52M
Net Cash Per Share	-3.09
Equity (Book Value)	253.24M
Book Value Per Share	3.33
Working Capital	-10.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.00 million and capital expenditures -4.25 million, giving a free cash flow of -1.25 million.

Operating Cash Flow	3.00M
Capital Expenditures	-4.25M
Free Cash Flow	-1.25M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 25.64%, with operating and profit margins of 0.88% and -14.57%.

Gross Margin	25.64%
Operating Margin	0.88%
Pretax Margin	-15.35%
Profit Margin	-14.57%
EBITDA Margin	8.86%
EBIT Margin	0.88%
FCF Margin	n/a

Dividends & Yields

Atrys Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	-14.69%
FCF Yield	-0.58%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Atrys Health has an Altman Z-Score of 0.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.6
Piotroski F-Score	n/a